Malignant Peritoneal Neoplasm Recruiting Phase 1 Trials for Ipilimumab (DB06186)

Also known as: Peritoneal Cancer / Malignant neoplasm of peritoneum, unspecified / Malignant peritoneal neoplasm NOS

IndicationStatusPhase
DBCOND0073968 (Malignant Peritoneal Neoplasm)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03508570Nivolumab With or Without Ipilimumab in Treating Patients With Recurrent or High Grade Gynecologic Cancer With Metastatic Peritoneal CarcinomatosisTreatment